Zai Lab Donates RMB 1 Million to coronavirus relief efforts in Hubei Province
On January 26, 2020, Zai Lab announced that it would donate RMB 1 million to the Hubei Charity Federation for coronavirus relief efforts in Hubei Province.
The donation would mainly be used to purchase protective materials such as protective clothing, surgical gowns, protective goggles, face masks, and disinfectants to help address a severe shortage of such items in Wuhan and surrounding areas.
About Zai Lab
Zai Lab (NASDAQ: ZLAB) is a China and U.S.-based innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Zai Lab’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast-growing segments of China's pharmaceutical market and addressing unmet medical needs. Zai Lab's vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners' and its own products in order to impact human health worldwide.